ATRIANCE ® (nelarabine) is indicated for the treatment of patients with T-cell acute lymphoblastic leukemia and T-cell lymphoblastic lymphoma whose disease has not responded to or has relapsed following treatment with at least two chemotherapy regimens. Approval is based on the unconfirmed surrogate endpoint of clinical response only.
Quote From www.gsk.ca
Atriance is used to treat patients with T-cell acute lymphoblastic leukaemia (T-ALL) or T-cell lymphoblastic lymphoma (T-LBL). These are types of cancer where T-lymphoblasts (a type of immature white blood cell) multiply too quickly. In T-ALL the abnormal cells are mainly in the blood and bone marrow, and in T-LBL they are mainly in the lymphatic system (lymph nodes or thymus gland). Atriance is used when patients have failed to respond to, or have stopped responding to, at least two types of chemotherapy.
The medicine can only be obtained with a prescription.
Quote From www.ema.europa.eu
Atriance solution for infusion is a clear, colourless solution. It is provided in clear glass vials with a rubber stopper and sealed with an aluminium cap.
Each vial contains 50 ml.
Atriance is supplied in packs of 6 vials.
Please contact +91-8130290915 | +91-120–2400370 for price of Atriance in India
We take guarantee of quality and delivery anywhere in the world as per the buyer’s requirements.
IKRIS PHARMA NETWORK connects buyer with the supplier who can ship Atriance (Cancer Treatment Medicines) to any country of the world as per the buyer's requirement and Government regulations of the country. Atriance is manufactured by Novartis Europharm Limited .
IKRIS PHARMA NETWORK provides options of choosing exporter and supplier of Cancer treatment Medicines
Atriance is a (prescription drug, prescription medication or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.
IKRIS Pharma Network facilitates import of cancer medicines on the named patient supply. IKRIS Pharma Network is facilitator providing input
Atriance can be made available Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore and Pune and other cities in India"
IKRIS Pharma Network can facilitate the supply of Atriance (prescription medicines) to all locations in the world and in India after fulfilling the legal requirement (if applicable)
The order will be confirmed only after the receipt of
Cost of Atriance® 5 mg/ml solution for infusion in Australia, Brazil, China, Canada, Eqypt, Europe, France, Germany, Hongkong, India, Iran, Italy, Mexico, Pakistan, Poland, Spain, Singapore, Thailand, Russia, Romania, UK, Middle East, UAE, Ukraine.
Disclaimer under the medicine image:
This image has been reproduced from publicly available sources for educational and general informational purposes only. Ikris Pharma Network is not and does not claim to be the licensee or owner of this image and neither is Ikris Pharma Network related to the image’s true owner in any capacity whatsoever including but not limited to parent, subsidiary, distributor or agent.
General disclaimer under Facts and usage:
Please note that all information in relation to this drug is of general nature and may not be applicable to your specific situation and circumstance. Any information available here is not a substitute for professional medical advice by a licensed practitioner. We will help you in importing this medicine only upon the valid prescription of a licensed medical practitioner and other documents as required by the laws of the jurisdiction in which you are present.
General disclaimer under where can I buy the medicine/is the medicine available in India:
Please note that Ikris Pharma Network is a consultancy company, which facilitates patients, hospitals, clinicians and researchers in accessing products, which are not available or approved in their home country. Ikris Pharma Network has no relation whatsoever with this medicine including but not limited to being its manufacturer, seller, reseller, distributor, agent or licensee. Ikris Pharma will not purchase this medicine but will only assist you in doing so against a valid prescription and other documents as required by the laws of the jurisdiction in which you are present. None of the trademarks and other intellectual property and proprietary marks of this medicine belong to or are claimed to belong to the Ikris Pharma Network.